Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,280.00    5.00 (0.39%)
Bid:
1,230.00
Ask:
1,305.00
Spread: 75.00 (6.098%)
Market Cap: £179.20m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Interim Management Statement

8 Aug 2011 11:45

RNS Number : 9283L
Oryx International Growth Fund Ld
08 August 2011
 

ORYX INTERNATIONAL GROWTH FUND LIMITED

 8 August 2011

 INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 30 JUNE 2011

Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FSA Handbook.

This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

This interim management statement relates to the period from 1 April 2011 to 30 June 2011, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 Manager's Review

Markets drifted for the majority of the period under review with the FTSE Small Cap TR Index up 0.7% and the FTSE All-Share TR Index (£) down 0.9%. It is pleasing to report that against this backdrop the net asset value rose by 8.8% to 296p per share. The increase in the portfolio was broadly based, although there was no movement in the value of the unquoted portfolio. Whilst current market conditions are difficult the manager believes there is inherent value in the portfolio which will be realised in the next quarter.

Material TransactionsSince 1 April 2011 the Company has purchased for cancellation the following shares:

15 April 2011 a total of 250,000 ordinary shares at a gross price of £2.30 per share.27 May 2011 a total of 170,000 ordinary shares at a gross price of £2.30 per share.

Material EventsThere were no material events during the quarter ended 30 June 2011.

Report and AccountsOn 30 June 2011, the Company posted its Annual Report for the year ended 31 March 2011 to Shareholders together with a circular containing the Notice convening the Company's AGM at 11am on 12 August 2011 and details of a proposed waiver of the Rule 9 provisions of the City Code on Takeovers and Mergers.

 

Financial Highlights

 

 

30 June 2011

31 March 2011

31 December 2010

30 June 2010

 

 

 

 

 

NAV

£2.96

£2.72

£2.81

£2.35

 

 

 

 

 

US Dollar / Sterling Exchange Rate

 1.6055

 1.6029

 1.5657

 1.4961

 

 

 

 

 

 

 

Twenty Largest Equity Investments at 30 June 2011

 

% Net Assets

RPC Group Plc

7.60

CVS Group Plc

7.01

Guinness Peat Group Plc

6.72

BBA Aviation Plc

6.38

Gleeson (M.J.) Group Plc

6.11

Augean

5.34

Orthoproducts Ltd

4.68

Quarto Group Inc

4.54

GTL Resources Plc

4.19

Bavaria Industriekapital AG

4.02

Idox Plc

3.92

Sinclair Pharma Plc

3.51

Innovation Group Plc

3.39

Catalyst Media Group Plc

3.38

Redhall Group Plc

3.21

Journey Group Plc

2.99

Nastor Inv Ltd Zero Redeem Prefer Shares

2.38

Bionostics Holdings Ltd

2.19

Green Co2 Plc

2.13

Celsis AG

1.64

85.33

 

The financial information for the quarter ended 30 June 2011 contained within this Interim Management Statement has not been audited.

By order of the Board

BNP Paribas Fund Services (Guernsey) Limited, for and on behalf ofOryx International Growth Fund Limitedas Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUGUUPRUPGGUR
Date   Source Headline
25th Oct 202112:09 pmRNSTransaction in Own Shares
11th Oct 202110:25 amRNSNet Asset Value(s)
23rd Sep 20214:32 pmRNSMajor liquidity events totalling £43 million
8th Sep 20212:13 pmRNSNet Asset Value(s)
27th Aug 202112:30 pmRNSResult of Annual General Meeting
9th Aug 20213:12 pmRNSNet Asset Value(s)
27th Jul 20216:00 pmRNSNotice of AGM
14th Jul 202111:45 amRNSNet Asset Value(s)
8th Jul 202111:42 amRNSAnnual Financial Report
9th Jun 20218:24 amRNSNet Asset Value(s)
3rd Jun 20212:44 pmRNSHolding(s) in Company - Replacement
3rd Jun 202112:51 pmRNSHolding(s) in Company
3rd Jun 20217:02 amRNSHolding(s) in Company
3rd Jun 20217:01 amRNSHolding(s) in Company
3rd Jun 20217:00 amRNSHolding(s) in Company
13th May 202111:21 amRNSNet Asset Value(s)
14th Apr 202111:42 amRNSNet Asset Value(s)
24th Mar 202110:26 amRNSHolding(s) in Company
22nd Mar 20216:27 pmRNSHolding(s) in Company
12th Mar 20213:37 pmRNSHolding(s) in Company
12th Mar 202111:01 amRNSNet Asset Value(s)
5th Mar 20219:02 amRNSHolding(s) in Company
4th Mar 202112:30 pmRNSHolding(s) in Company
1st Mar 20211:49 pmRNSTotal Voting Rights
26th Feb 20215:04 pmRNSHolding(s) in Company
25th Feb 20214:21 pmRNSHolding(s) in Company
17th Feb 20211:11 pmRNSHolding(s) in Company
12th Feb 202112:25 pmRNSTransaction in Own Shares
11th Feb 20216:00 pmRNSHolding(s) in Company
11th Feb 202110:49 amRNSNet Asset Value(s)
22nd Jan 20214:00 pmRNSHolding(s) in Company
22nd Jan 202111:09 amRNSHolding(s) in Company
20th Jan 20214:25 pmRNSNet Asset Value(s)
20th Jan 20219:50 amRNSHolding(s) in Company
18th Jan 20213:32 pmRNSHolding(s) in Company
15th Jan 20211:23 pmRNSHolding(s) in Company
4th Jan 20214:28 pmRNSTR-1: Notification of major holdings
4th Jan 20211:38 pmRNSTR1: Notification of major shareholding
4th Jan 202111:26 amRNSHoldings in Company
4th Jan 20217:30 amRNSHolding(s) in Company
31st Dec 20201:04 pmRNSTR-1
23rd Dec 202012:43 pmRNSHolding(s) in Company
21st Dec 20203:57 pmRNSNet Asset Value(s)
11th Dec 20201:05 pmRNSHolding(s) in Company
10th Dec 20201:55 pmRNSHalf-year Report
3rd Dec 20205:08 pmRNSTR-1
1st Dec 20204:41 pmRNSHolding(s) in Company
26th Nov 20201:08 pmRNSTR-1
25th Nov 20202:06 pmRNSHolding(s) in Company
23rd Nov 202012:25 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.